Coeliac disease and C virus-related chronic hepatitis: A non association

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Gravina, Antonietta Gerarda ^a   Federico, Alessandro ^a   Masarone, Mario ^a   Cuomo, Antonio ^b   Tuccillo, Concetta ^a   Loguercio, Carmelina ^a   Persico, Marcello ^a   Romano, Marco ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Umberto i Hospital   (Italy)

Author keywords

interferon therapy; Coeliac disease; HCV related chronic hepatitis; Liver

Indexed keywords

HEPATITIS C VIRUS;

ALPHA INTERFERON; ANTIVIRUS AGENT; AUTOANTIBODY; HEPATITIS C ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE TRANSGLUTAMINASE 2, HUMAN; VIRUS RNA;

ADULT; ARTICLE; BLOOD; CELIAC DISEASE; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ITALY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; AUTOANTIBODIES; CELIAC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; ITALY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TRANSGLUTAMINASES; VIRAL LOAD;

MLCS; MLOWN;

EID: 84866540326     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-533     Document Type: Article

References (29)

1. Clinical features of celiac disease. Biagi F, Corazza GR, Dig Liver Dis 2002 34 225 228 10.1016/S1590-8658(02)80197-9 11990396 (Pubitemid 34269570)
2. Prevalence of celiac disease among children in Finland. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Höpfl P, Knip M, N Engl J Med 2003 348 2517 2524 10.1056/NEJMoa021687 12815137 (Pubitemid 36706539)
3. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK, Khaw KT, Gut 2003 52 960 965 10.1136/gut.52.7.960 12801951 (Pubitemid 36765286)
4. Identification of tissue transglutaminase as the autoantigen of celiac disease. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D, Nat Med 1997 3 797 801 10.1038/nm0797-797 9212111 (Pubitemid 27298728)
5. Molecular basis of celiac disease. Sollid LM, Annu Rev Imm 2000 18 53 81 10.1146/annurev.immunol.18.1.53 (Pubitemid 30365374)
6. Epidemiology and economic burden of viral hepatitis: an observational population based study. Steinke DT, Weston TL, Morris AD, MacDonald TM, Dillon JF, Gut 2002 50 100 105 10.1136/gut.50.1.100 11772975 (Pubitemid 34028311)
7. Extrahepatic manifestations of HCV infection: facts and controversies. Zignego AL, Brèchot C, J Hepatol 1999 31 369 376 10.1016/S0168-8278(99) 80239-6 10453955 (Pubitemid 29349768)
8. Prevalence and incidence of cryoglobulins in hepatitis C virus-related chronic hepatitis patients: a prospectic study. Persico M, De Marino FA, Di Giacomo Russo G, Persico E, Morante A, Palmentieri B, Torella R, Am J Gastroenterol 2003 98 884 888 12738472 (Pubitemid 36576318)
9. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J, Am J Gastroenterol 2001 96 138 145 10.1111/j.1572-0241.2001.03464.x 11197243 (Pubitemid 32104821)
10. Adult celiac disease and hypertransaminasemia. Múgica F, Aranzadi MJ, Recasens M, Almagro F, Muñagorri A, Elósegui E, Resano A, Huarte I, Rev Esp Enferm Dig 2000 92 78 85 10757865
11. Hepatic injury in adult coeliac disease. Hagander B, Berg NO, Brandt L, Nordén A, Sjölund K, Stenstam M, Lancet 1977 ii 270 272 (Pubitemid 8152956)
12. Prevalence and clinical significance of immunoglobulin A antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Germenis AE, Yiannaki EE, Zachou K, Roka V, Barbanis S, Liaskos C, Adam K, Kapsoritakis AN, Potamianos S, Dalekos GN, Clin Diagn Lab Immunol 2005 12 941 948 16085912
13. Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C. Teml A, Vogelsang H, Am J Gastroenterol 2001 96 2522 2523 10.1111/j.1572-0241.2001.04080.x 11513217 (Pubitemid 32769237)
14. Celiac disease during IFN treatment. Bardella M, Marino R, Meroni PL, Ann Intern Med 1999 131 157 158 10419441
15. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G, Lancet 2000 356 1494 1495 10.1016/S0140-6736(00)02880-4 11081540
16. Onset of celiac disease and interferon treatment. Bourlière M, Oulés V, Perrier H, Mengotti C, Lancet 2001 357 803 804 11253998 (Pubitemid 32217702)
17. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Adinolfi LE, Durante Mangoni E, Andreana A, Am J Gastroenterol 2001 96 607 608 10.1111/j.1572-0241.2001.03574.x 11232725
18. Chronic Hepatitis C Virus and Celiac Disease, is there an Association? Hernandez L, Johnson TC, Naiyer AJ, Kryszak D, Ciaccio EJ, Min A, Bodenheimer HC Jr, Brown RS Jr, Fasano A, Green PH, Dig Dis Sci 2008 53 256 261 10.1007/s10620-007-9851-z 17549632 (Pubitemid 350265678)
19. Single-step method of RNA isolation by aci guanidium thiocyanate-phenol- chloroform extraction. Chomczynski P, Sacchi N, Anal Biochem 1987 162 156 159 2440339 (Pubitemid 17064313)
20. Avoiding false positive with PCR. Kwok S, Higuchi R, Nature 1989 339 237 238 10.1038/339237a0 2716852
21. Typing of hepatits C virus isolates by DNA enzyme immunoassay. Viazov S, Zibert A, Ramakrishnan K, Widell A, Cavicchini A, Schreier E, Roggendorf M, J Virol Meth 1994 48 81 92 10.1016/0166-0934(94)90091-4
22. Histological grading and staging of chronic hepatitis. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H, J Hepatol 1995 22 696 699 10.1016/0168-8278(95)80226-6 7560864
23. Pathology of nonalcoholic fatty liver disease. Brunt EM, Nat Rev Gastroenterol Hepatol 2010 7 195 203 10.1038/nrgastro.2010.21 20195271
24. AGA technical review on celiac sprue. Ciclitira PJ, King A, Fraser J, Gastroenterology 2001 120 1526 1540 a. Watt, Switzerland 10.1053/gast.2001.24056 11313324 (Pubitemid 32322327)
25. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population. A community-based survey in southern Italy. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M, Hepatology 1997 26 1006 1011 10.1002/hep.510260431 9328327 (Pubitemid 27413671)
26. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Ferguson A, Arranz E, O'Mahony S, Gut 1993 34 150 151 10.1136/gut.34.2.150 8432463 (Pubitemid 23049101)
27. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alpha interferon. Fattovich G, Giustina G, Favarato S, Ruol A, J Hepatol 1996 24 38 47 8834023
28. Coeliac disease in chronic hepatitis C: a French multicentre prospective study. Thevenot T, Denis J, Jouannaud V, Monnet E, Renou C, Labadie H, Abdelli N, Nguyen-Khac E, Dumouchel P, Bresson-Hadni S, Chousterman M, Di Martino V, Cadranel JF, Aliment Pharmacol Ther 2007 26 1209 1216 10.1111/j.1365-2036.2007. 03499.x 17944735 (Pubitemid 47620422)
29. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection. Ruggeri C, La Masa AT, Rudi S, Squadrito G, Di Pasquale G, Maimone S, Caccamo G, Pellegrino S, Raimondo G, Magazzù G, Dig Dis Sci 2008 53 2151 2155 10.1007/s10620-007-0146-1 18231858